• Explore /
  • Poster
  • / Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) and brain metastases: Preliminary results from the GETUG-AFU 26 (Nivoren) study.

Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) and brain metastases: Preliminary results from the GETUG-AFU 26 (Nivoren) study.

Abstract Poster

Authors

null

Bernard J. Escudier

Gustave Roussy Cancer Campus, Villejuif, France

Bernard J. Escudier , Sylvie Chabaud , Delphine Borchiellini , Gwenaelle Gravis , Christine Chevreau , Pierre Emmanuel Brachet , Lionnel Geoffrois , Brigitte Laguerre , Hakim Mahammedi , Sylvie Negrier , Frederic Rolland , Marine Gross Goupil , Muriel Habibian , Laurence Albiges

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03013335

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4563)

DOI

10.1200/JCO.2017.35.15_suppl.4563

Abstract #

4563

Poster Bd #

241

Abstract Disclosures

Similar Posters

First Author: Hamid Emamekhoo

First Author: Laurence Albiges

First Author: Viacheslav Chubenko

First Author: Chiara Ciccarese